Cargando…

Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy

Genetic therapy has changed the prognosis of hereditary proximal spinal muscular atrophy, although treatment efficacy has been variable. There is a clear need for deeper understanding of underlying causes of muscle weakness and exercise intolerance in patients with this disease to further optimize t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Habets, Laura E, Bartels, Bart, Asselman, Fay-Lynn, Hooijmans, Melissa T, van den Berg, Sandra, Nederveen, Aart J, van der Pol, W Ludo, Jeneson, Jeroen A L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128825/ https://www.ncbi.nlm.nih.gov/pubmed/34788410 http://dx.doi.org/10.1093/brain/awab411

Ejemplares similares

Multi‐parametric quantitative magnetic resonance imaging of the upper arm muscles of patients with spinal muscular atrophy
por: Hooijmans, Melissa T., et al.
Publicado: (2022)

Respiratory muscle fatigability in patients with spinal muscular atrophy
por: Kant‐Smits, Kim, et al.
Publicado: (2022)

Fatigability in spinal muscular atrophy: validity and reliability of endurance shuttle tests
por: Bartels, Bart, et al.
Publicado: (2020)

The RESISTANT study (Respiratory Muscle Training in Patients with Spinal Muscular Atrophy): study protocol for a randomized controlled trial
por: Kant-Smits, Kim, et al.
Publicado: (2023)

Natural history of lung function in spinal muscular atrophy
por: Wijngaarde, Camiel A., et al.
Publicado: (2020)

Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study
por: Otto, Louise A.M., et al.
Publicado: (2021)

Randomized double-blind placebo-controlled crossover trial with pyridostigmine in spinal muscular atrophy types 2–4
por: Stam, Marloes, et al.
Publicado: (2022)

Feasibility and tolerability of multimodal peripheral electrophysiological techniques in a cohort of patients with spinal muscular atrophy
por: Ros, Leandra A.A., et al.
Publicado: (2023)

Parents’ perspectives on nusinersen treatment for children with spinal muscular atrophy
por: van Kruijsbergen, Mette, et al.
Publicado: (2021)

A continuous repetitive task to detect fatigability in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2018)

Quantitative MRI of skeletal muscle in a cross‐sectional cohort of patients with spinal muscular atrophy types 2 and 3
por: Otto, Louise A.M., et al.
Publicado: (2020)

Relative hyperventilation in non-ventilated patients with spinal muscular atrophy
por: Veldhoen, Esther S., et al.
Publicado: (2020)

Protocol for a phase II, monocentre, double-blind, placebo-controlled, cross-over trial to assess efficacy of pyridostigmine in patients with spinal muscular atrophy types 2–4 (SPACE trial)
por: Stam, Marloes, et al.
Publicado: (2018)

Longitudinal prospective cohort study to assess peripheral motor function with extensive electrophysiological techniques in patients with Spinal Muscular Atrophy (SMA): the SMA Motor Map protocol
por: Ros, Leandra A. A., et al.
Publicado: (2023)

Natural history of respiratory muscle strength in spinal muscular atrophy: a prospective national cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2022)

Magnetic resonance imaging of the cervical spinal cord in spinal muscular atrophy
por: Stam, Marloes, et al.
Publicado: (2019)

Population-based assessment of nusinersen efficacy in children with spinal muscular atrophy: a 3-year follow-up study
por: Scheijmans, Féline E V, et al.
Publicado: (2022)

Lung function decline preceding chronic respiratory failure in spinal muscular atrophy: a national prospective cohort study
por: Veldhoen, Esther S., et al.
Publicado: (2023)

Assessment of fatigability in patients with spinal muscular atrophy: development and content validity of a set of endurance tests
por: Bartels, Bart, et al.
Publicado: (2019)

Innovating spinal muscular atrophy models in the therapeutic era
por: Signoria, Ilaria, et al.
Publicado: (2023)

Validation of a Fast, Robust, Inexpensive, Two-Tiered Neonatal Screening Test algorithm on Dried Blood Spots for Spinal Muscular Atrophy
por: Strunk, Annuska, et al.
Publicado: (2019)

Electrophysiological and Imaging Biomarkers to Evaluate Exercise Training in Patients with Neuromuscular Disease: A Systematic Review
por: Pomp, Lisa, et al.
Publicado: (2023)

Cardiac pathology in spinal muscular atrophy: a systematic review
por: Wijngaarde, C. A., et al.
Publicado: (2017)

Intragenic and structural variation in the SMN locus and clinical variability in spinal muscular atrophy
por: Wadman, Renske I, et al.
Publicado: (2020)

Mastication in Patients with Spinal Muscular Atrophy Types 2 and 3 is Characterized by Abnormal Efficiency, Reduced Endurance, and Fatigue
por: van der Heul, A. M. B., et al.
Publicado: (2021)

Spinal Muscular Atrophy Patient iPSC-Derived Motor Neurons Display Altered Proteomes at Early Stages of Differentiation
por: Varderidou-Minasian, Suzy, et al.
Publicado: (2021)

Limited maximal mouth opening in patients with spinal muscular atrophy complicates endotracheal intubation: An observational study
por: Wijngaarde, Camiel A., et al.
Publicado: (2018)

A Comparative Study of SMN Protein and mRNA in Blood and Fibroblasts in Patients with Spinal Muscular Atrophy and Healthy Controls
por: Wadman, Renske I., et al.
Publicado: (2016)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

European ad-hoc consensus statement on gene replacement therapy for spinal muscular atrophy
por: Kirschner, Janbernd, et al.
Publicado: (2020)

Analysis of FUS, PFN2, TDP-43, and PLS3 as potential disease severity modifiers in spinal muscular atrophy
por: Wadman, Renske I., et al.
Publicado: (2019)

SMN1 Duplications Are Associated With Progressive Muscular Atrophy, but Not With Multifocal Motor Neuropathy and Primary Lateral Sclerosis
por: Bos, Jeroen W., et al.
Publicado: (2021)

Modeling Spinal Muscular Atrophy in Drosophila
por: Chang, Howard Chia-Hao, et al.
Publicado: (2008)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Spinal Muscular Atrophy and Ependymoma
por: Albakr, Aishah, et al.
Publicado: (2017)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Lowering EphA4 Does Not Ameliorate Disease in a Mouse Model for Severe Spinal Muscular Atrophy
por: Poppe, Lindsay, et al.
Publicado: (2019)

Spinal Muscular Atrophy: Mutations, Testing, and Clinical Relevance
por: Keinath, Melissa C, et al.
Publicado: (2021)

Carrier screening for spinal muscular atrophy
por: Prior, Thomas W.
Publicado: (2008)

Androgens in spinal and bulbar muscular atrophy
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f3tcg0c40r026ss7vv5isgmep9